Buy Aurobindo Pharma, target price Rs 763: ICICI Direct
Aurobindo Pharma with a target price of Rs 763. The current market price of Aurobindo Pharma is Rs 756.5.
Time period given by analyst is Intra Day when Aurobindo Pharma price can reach defined target. ICICI Direct recommended to keep stop loss at Rs 745.9.
Aurobindo Pharma, incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 44792.08 Crore) operating in Pharmaceuticals sector. Aurobindo Pharma key Products/Revenue Segments include Pharmaceuticals, Sale of services, Export Incentives and Scrap for the year ending 31-Mar-2022.Financials For the quarter ended 31-03-2023, the company has reported a Consolidated Total Income of Rs 6607.87 Crore, up 1.66 % from last quarter Total Income of Rs 6499.78 Crore and up 12.80 % from last year same quarter Total Income of Rs 5858.25 Crore.
Company has reported net profit after tax of Rs 511.77 Crore in latest quarter. The company’s top management includes Mr.K Ragunathan, Mr.K Nithyananda Reddy, Mr.P Sarath Chandra Reddy, Dr.M Sivakumaran, Mr.M Madan Mohan Reddy, Mr.P V Ramprasad Reddy, Mrs.Savita Mahajan, Mr.Girish P Vanvari, Dr.(Mrs.)Avnit Bimal Singh.
Company has BSR & Associates LLP as its auditors. As on 31-03-2023, the company has a total of 59 Crore shares outstanding. Investment Rationale Price moving out of short term consolidation range and higher base formation above 20 day EMA signaling further northward journey in coming sessions.Promoter/FII Holdings Promoters held 51.83 per cent stake in the company as of 31-Mar-2023, while FIIs owned 23.03 per cent, DIIs 15.09 per cent.
. Read more on economictimes.indiatimes.com
